MULTICENTRIC, PERSPECTIVE, RANDOMIZED TRIAL TO ASSESS THE INTRAOPERATIVE USE OF HYPERTHERMIC CHEMOTHERAPY IN LOCALLY ADVANCED NON SMALL CELL LUNG CANCER. COMPARISON BETWEEN LOCO-REGIONAL + SYSTEMIC CHEMOTHERAPY VS CONVENTIONAL TREATMENT - HTIPC
- Conditions
- ON SMALL CELL LUNG CANCER PATIENTSMedDRA version: 9.1Level: HLTClassification code 10024973Term: Lower respiratory tract neoplasms
- Registration Number
- EUCTR2007-005980-83-IT
- Lead Sponsor
- CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- T2, T3, T4 N0 N1 M0 NON SMALL CELL LUNG CANCER
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- M1, T1
- OTHER NEOPLASTIC DISEASES
- RENAL, HEPATIC, BONE MARROW FAILURE
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: GLOBAL SURVIVAL EVALUATION;Secondary Objective: - DISEASE FREE SURVIVAL<br>- MORTALITY AND MORBIDITY<br>- RISK FACTORS<br>- TOXICITY<br>- POSITIVE PREDICTIVE FACTORS TO LOCO-REGIONAL TREATMENT;Primary end point(s): GLOBAL SURVIVAL EVALUATIO
- Secondary Outcome Measures
Name Time Method